Special Seminar in Melanoma Biology
Professor Dr. Meenhard Herlyn from The Wistar Institute, Philadelphia, USA, has special research interests in melanoma biology. He has published more than 500 papers in high profile journals including Cell, Cancer Cell and JCI. His special seminar at TRI will focus on recent advances in our understanding of melanoma development new therapeutic targets and drug resistance.
